Exchange: NASDAQ·Updated 04:15 PM EST

About INKT

About

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
15

Frequently Asked Questions

Advertisement|Remove ads.